Business Description
Coegin Pharma
ISIN : SE0020357754
Share Class Description:
NGM:COEGIN: Ordinary SharesCompare
Compare
Traded in other countries / regions
COEGIN.Sweden IPO Date
2018-02-21Description
Coegin Pharma AB is a biotechnology company that focuses on the development of small molecule therapies for the treatment of inflammatory diseases such as cancer and kidney disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 57.2 | |||||
| 3-Year EPS without NRI Growth Rate | 29.6 | |||||
| 3-Year FCF Growth Rate | 25.5 | |||||
| 3-Year Book Growth Rate | -38.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.71 | |||||
| 9-Day RSI | 48.05 | |||||
| 14-Day RSI | 46.88 | |||||
| 6-1 Month Momentum % | -44.97 | |||||
| 12-1 Month Momentum % | -23.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.66 | |||||
| Quick Ratio | 8.66 | |||||
| Cash Ratio | 8.06 | |||||
| Days Payable | 25860.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.7 | |||||
| Shareholder Yield % | -28.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -119.47 | |||||
| ROA % | -101.54 | |||||
| ROIC % | -158.97 | |||||
| ROC (Joel Greenblatt) % | -9050 | |||||
| ROCE % | -117.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.38 | |||||
| Price-to-Tangible-Book | 2.98 | |||||
| EV-to-EBIT | -3.64 | |||||
| EV-to-EBITDA | -4.16 | |||||
| EV-to-FCF | -3.91 | |||||
| Price-to-Net-Current-Asset-Value | 8.86 | |||||
| Price-to-Net-Cash | 9.51 | |||||
| Earnings Yield (Greenblatt) % | -27.47 | |||||
| FCF Yield % | -23.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coegin Pharma Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -1.617 | ||
| Beta | 0 | ||
| Volatility % | 114.04 | ||
| 14-Day RSI | 46.88 | ||
| 14-Day ATR (kr) | 0.350619 | ||
| 20-Day SMA (kr) | 3.8945 | ||
| 12-1 Month Momentum % | -23.13 | ||
| 52-Week Range (kr) | 2.43 - 8.86 | ||
| Shares Outstanding (Mil) | 24.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coegin Pharma Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coegin Pharma Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Coegin Pharma Frequently Asked Questions
What is Coegin Pharma(NGM:COEGIN)'s stock price today?
The current price of NGM:COEGIN is kr3.90. The 52 week high of NGM:COEGIN is kr8.86 and 52 week low is kr2.43.
When is next earnings date of Coegin Pharma(NGM:COEGIN)?
The next earnings date of Coegin Pharma(NGM:COEGIN) is 2025-02-27.
Does Coegin Pharma(NGM:COEGIN) pay dividends? If so, how much?
Coegin Pharma(NGM:COEGIN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers